EBOS issues new shares under dividend reinvestment plan

The latest update is out from EBOS Group Limited ( (AU:EBO) ).

EBOS Group Limited has issued 1,878,380 fully paid ordinary shares at NZ$22.09 per share under its Dividend Reinvestment Plan, following shareholder elections to reinvest their latest dividend. The new stock will be quoted on both NZX and ASX, increasing the company’s ordinary shares on issue to 206,924,049 and modestly bolstering equity capital without raising external cash.

The DRP issuance represents about 0.916% of EBOS’s ordinary share base, reflecting continued shareholder uptake of script-based dividends in the healthcare distributor. By using a DRP rather than an all-cash payout, EBOS preserves cash on its balance sheet for ongoing operational and growth needs, while slightly diluting existing holdings and broadening its free float in the Australasian market.

More about EBOS Group Limited

EBOS Group Limited, listed on the NZX and ASX under ticker EBO, is an Australasian healthcare and pharmaceutical distributor and marketer. The company issues ordinary fully paid shares and operates a Dividend Reinvestment Plan (DRP) that allows shareholders to take dividends in the form of additional equity rather than cash.

Find detailed analytics on EBO stock on TipRanks’ Stock Analysis page.